A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

Peer Review reports

Original Submission
11 Oct 2013	Submitted	Original manuscript
2 Nov 2013	Reviewed	Reviewer Report - Andres Cervantes
19 Nov 2013	Reviewed	Reviewer Report - Mogens Karsbøl Boisen
8 Dec 2013	Author responded	Author comments - George Pentheroudakis
Resubmission - Version 2
8 Dec 2013	Submitted	Manuscript version 2
18 Dec 2013	Author responded	Author comments - George Pentheroudakis
Resubmission - Version 3
18 Dec 2013	Submitted	Manuscript version 3
Publishing
11 Feb 2014	Editorially accepted
20 Feb 2014	Article published	10.1186/1471-2407-14-111

Back to article page